Redona Therapeutics is focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), they can use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.

Therapeutics

Biotechnology

Redona Therapeutics

Co-Founders

Kazumi Shiosaki

Edward Darr

Richard Gregory

George Daley

Frank Slack

Piotr Sliz

Shomir Ghosh

Twentyeight-Seven Therapeutics' Leadership Team includes Darren Harvey and 4 others.

Leadership Team

��

Leadership Team

About

Team members

��������

Leadership Team

About

Team members

��